Wave Life Sciences rises; JP Morgan resumes coverage with 'overweight'

Wave Life Sciences

27/09/2024 11:54

** Biotechnology company Wave Life Sciences'  WVE.O  shares
rise about ~1.25% to $8.12 premarket
    ** J.P. Morgan resumes coverage with "overweight" rating,
price target of $13
    ** 9 of 10 brokerages rate WVE stock "buy" or higher, 1
"hold"; their median PT is $16 - LSEG data
    ** As of previous close, stock up nearly 59% YTD

 (Reporting by Prakhar Srivastava in Bengaluru)
 ((Prakhar.Srivastava2@thomsonreuters.com;))